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The quest for universal health coverage: achieving social
protection for all in Mexico
Felicia Marie Knaul, Eduardo González-Pier, Octavio Gómez-Dantés, David García-Junco, Héctor Arreola-Ornelas, Mariana Barraza-Lloréns,
Rosa Sandoval, Francisco Caballero, Mauricio Hernández-Avila, Mercedes Juan, David Kershenobich, Gustavo Nigenda, Enrique Ruelas,
Jaime Sepúlveda, Roberto Tapia, Guillermo Soberón, Salomón Chertorivski*, Julio Frenk*

Mexico is reaching universal health coverage in 2012. A national health insurance programme called Seguro Popular,
introduced in 2003, is providing access to a package of comprehensive health services with ﬁnancial protection for more
than 50 million Mexicans previously excluded from insurance. Universal coverage in Mexico is synonymous with social
protection of health. This report analyses the road to universal coverage along three dimensions of protection: against
health risks, for patients through quality assurance of health care, and against the ﬁnancial consequences of disease and
injury. We present a conceptual discussion of the transition from labour-based social security to social protection of
health, which implies access to eﬀective health care as a universal right based on citizenship, the ethical basis of the
Mexican reform. We discuss the conditions that prompted the reform, as well as its design and inception, and we describe
the 9-year, evidence-driven implementation process, including updates and improvements to the original programme.
The core of the report concentrates on the eﬀects and impacts of the reform, based on analysis of all published and
publically available scientiﬁc literature and new data. Evidence indicates that Seguro Popular is improving access to health
services and reducing the prevalence of catastrophic and impoverishing health expenditures, especially for the poor.
Recent studies also show improvement in eﬀective coverage. This research then addresses persistent challenges,
including the need to translate ﬁnancial resources into more eﬀective, equitable and responsive health services. A next
generation of reforms will be required and these include systemic measures to complete the reorganisation of the health
system by functions. The paper concludes with a discussion of the implications of the Mexican quest to achieve universal
health coverage and its relevance for other low-income and middle-income countries.

Introduction
A central topic in the global agenda is universal health
coverage. WHO has deﬁned universal coverage as access
of all people to comprehensive health services at
aﬀordable cost and without ﬁnancial hardship through
protection against catastrophic health expenditures.1
Universal health coverage is a quest with three stages:
(1) universal enrolment, a term closely associated with
legal coverage, entitles all people to beneﬁt from
health services funded by publicly organised insurance;
(2) coverage that is universal implies regular access to a
comprehensive package of health services with ﬁnancial
protection for all; and (3) universal eﬀective coverage
guarantees to all on an equal basis, the maximum
attainable health results from an appropriate package of
high-quality services that also prevents ﬁnancial shocks
by reducing out-of-pocket payments.2,3
These stages tend to be progressive but with an
important degree of overlap. As enrolment proceeds to
include the entire population, the package of covered
health services expands, thus increasing the level of
ﬁnancial protection. Simultaneously, quality improves as
the system adjusts to meet new demands. In fact, the
2010 World Health Report highlights the tradeoﬀs
between three essential dimensions of universality of
coverage: who (enrolment), which services, and what
proportion of direct costs (ﬁnancial protection).1
Mexico has advanced signiﬁcantly in the quest for
universal coverage—particularly on the ﬁrst two stages—
as a result of the 2003 health reform that legislated the
System of Social Protection in Health (SSPH) and
www.thelancet.com Vol 380 October 6, 2012

Constitutional reform implemented in 1983. The third
stage is a continuous challenge. As for all countries,
quality of care is a moving target for Mexico.
In 2012, after 9 years of implementation, the country
reached a major milestone in universal coverage. As of
April, 52·6 million Mexicans, previously uninsured,
were incorporated into the SSPH and the budgetary
allocation for universal coverage was achieved.4 The
implementation experience is relevant for other countries
undergoing similar reforms.
The most prominent component of SSPH is Seguro
Popular. This public insurance scheme oﬀers universal
access to a comprehensive package of personal health
services with ﬁnancial protection, thus guaranteeing the
eﬀective exercise of the right to health protection. This
right is recognised in the Mexican Constitution of 1983,
yet had been denied to the majority of the population.
The vision of the reform was to reorganise the health
system by functions, improve equity and eﬃciency, and
achieve eﬀective universal coverage. The stewardship
function is the ultimate responsibility of a strengthened
Ministry of Health. Financing is done by a new
public insurance scheme that supersedes the existing
employment-based social insurance mechanisms limited
to salaried workers. Lastly, services are delivered by a
plurality of accredited providers, public and private.5–7
This vision has been partly implemented, yet continuous
challenges point to the need for new reforms.
The initial steps of the reform were discussed in a
2006 Lancet Series.8–14 With only 3 years of experience,
this Series focused on the initial challenges and lessons

Lancet 2012; 380: 1259–79
Published Online
August 16, 2012
http://dx.doi.org/10.1016/
S0140-6736(12)61068-X
See Editorial Lancet 2012;
380: 622
For The Lancet podcast on
Mexico’s quest for universal
health coverage see http://
download.thelancet.com/
ﬂatcontentassets/audio/
lancet/2012/16august-eng.mp3
(English) and http://download.
thelancet.com/ﬂatcontentassets/
audio/lancet/2012/16augustesp.mp3 (Spanish)
*Joint last authorship and
group leaders
Harvard Global Equity
Initiative, Boston, MA, USA
(F M Knaul PhD, G Nigenda PhD);
Mexican Health Foundation,
Mexico City, Mexico (F M Knaul,
H Arreola-Ornelas MSc,
M Juan MD, G Soberón PhD);
Mexican Institute of Social
Security, Mexico City, Mexico
(E González-Pier PhD,
M Barraza-Lloréns MSc);
National Institute of Public
Health of Mexico, Cuernavaca,
Mexico (O Gómez-Dantés MPH,
M Hernández-Avila PhD);
National Commission of Social
Protection in Health,
Mexico City, Mexico
(D García-Junco MSc,
R Sandoval PhD); Ministry of
Health of Mexico, Mexico City,
Mexico (F Caballero MSc,
S Chertorivski MSc); National
Institute of Medical Sciences
and Nutrition Salvador
Zubiran, Mexico City, Mexico
(D Kershenobich MD); National
Academy of Medicine of
Mexico, Mexico City, Mexico,
and Institute for Healthcare
Improvement, Cambridge,
MA, USA (E Ruelas MD); Global
Health Sciences, University of
California, San Francisco, CA,
USA (J Sepúlveda MD); Carlos
Slim Health Institute, Mexico
City, Mexico (R Tapia MD); and
Harvard School of Public
Health, Boston, MA, USA
(J Frenk PhD)

1259

Health Policy

Correspondence to:
Felicia M Knaul, Harvard Global
Equity Initiative, Boston, MA, USA
felicia_knaul@harvard.edu

of broad reform. Since then, implementation across
two governmental administrations has produced
substantial advances in the pursuit of universal
coverage. At the same time, expansions in enrolment
and covered services exposed unforseen hurdles and
unmet needs.
This report analyses the road to universal health
coverage in Mexico, including present challenges, future
policy proposals, and worldwide implications. The ﬁrst
part is a conceptual discussion of the transition from
labour-market-based social security, to social protection
of health, the universal right of access to eﬀective health
care based on the sole requirement of citizenship for
inclusion.2 Part two describes the design and initial phase
of the health reform in Mexico, the creation of the SSPH,
and the conditions that prompted the reform. Part three
describes the implementation process with a focus on
how evidence prompted policy dynamism, and hence
improvements on the initial reform design. Part four
concentrates on the eﬀects of the reform, on the basis of
the analysis of all published and publicly available
documentation on Seguro Popular. Part ﬁve addresses the
successes and challenges of implementation of SSPH.
The next section discusses the future generation of
reforms—the measures needed to reorganise by functions and better integrate the major institutional
segments of the Mexican health system to increase
eﬃciency and guarantee universal access and egalitarian
exercise of the right to social protection of health. This
report concludes with a discussion of lessons learned
from the Mexican quest to achieve universal coverage
and their worldwide relevance.

Universal health coverage and social protection
of health
If health is to be a truly universal right, it is essential to
decouple access to insurance from formal, salaried
employment, and to adopt a comprehensive notion of
social protection of health. A comprehensive approach has
three major dimensions: (1) protection against health risks

Social
protection
in health

Dimension

Main actions

Policy instruments of the
Mexican Reform

Protection
against
health risk

• Epidemiological
surveillance
• Health promotion
• Disease prevention
• Risk mitigation

• New public health agency
• Health card scheme with gender
and life-course perspective
• Fund for community health services

Patient
protection

• Quality of care
assurance:
• Safety
• Eﬀectiveness
• Responsiveness

• National Crusade for
Health Quality

• Comprehensive
health insurance

• Seguro Popular:
• Fund for essential health services
• Fund for protection against
catastrophic health expenditures

Financial
protection

Figure 1: Dimensions of social protection in health
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through surveillance, preventive, and regulatory activities;
(2) protection of patients through quality assurance of
health care; (3) and ﬁnancial protection against the
economic consequences of disease and injury.15,16
The essential responsibility of the State is the protection
of its citizens against threats or downside risk: natural
disasters, environmental degradation, insecurity, and
violations of the physical integrity and rights of
individuals.17 This encompasses physical, environmental,
legal, and civil protection.
Social protection is an additional dimension of this
essential responsibility, which the International Labour
Oﬃce deﬁnes as “the protection which society provides
for its members through a series of public measures”.18
The ultimate purpose of social protection is to expand
human capabilities, which allow citizens to fully enjoy
their economic, social, and cultural rights.19 Expansion of
these capabilities increases the freedom of individuals,
strengthens social cohesion, and promotes overall individual and population-wide wellbeing.20
Yet, in many countries, the right to health care is an
employment beneﬁt, restricted to the salaried workforce.
Although traditional social security is a major component
of social protection and provides access to health care and
other programmes aimed at protecting family income,
access is restricted. Thus, conceiving social protection as
an employment beneﬁt has major limitations both in
terms of attainment of universal coverage and for
expansion of other social beneﬁts. These limitations are
particularly severe in countries where a large share of the
population are non-salaried, independent workers or do
not participate in the labour market.21
A growing global movement for universal coverage is
advocating for the transformation of health care into
a universal right, which entails a transition from
traditional social insurance as an employment beneﬁt to
universal social protection of health, a right of citizenship.
Translation of this social right into practice implies a
continuous strengthening of health systems to enable
them to oﬀer eﬀective universal coverage.
In Mexico, institutional transformation was enabled by
establishing the SSPH through health reform. Universal
health coverage is synonymous with universal social
protection of health and includes a comprehensive
package of personal and non-personal health services
spanning promotion, prevention, treatment, and rehabilitation. Social protection is distinguished from
traditional employment-based social security because it
is not dependent on labour market participation.

The Mexican health reform: design and
execution
The 2003 reform established a system encompassing
all three dimensions—risk, patient, and ﬁnance—
embedded in the concept of social protection of health.
Speciﬁcally, public health interventions, institutions and
dedicated ﬁnancing are providing protection against
www.thelancet.com Vol 380 October 6, 2012
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health risks; system-wide initiatives that enhance patient
safety, eﬀectiveness, and responsiveness are protecting
the quality of health care; and Seguro Popular is continually
expanding protection against the ﬁnancial shocks of
disease and disability (ﬁgure 1).

Origins and precursors of the reform
Until the beginning of the present century, the Mexican
health system, like most in Latin America, was segmented and unequal.22 Table 1 and panel 1 describe the
basic characteristics of Mexico and its health system.
The insured population received health care from
well ﬁnanced, vertically-integrated, federal institutions,
whereas the uninsured relied on underfunded, statedecentralised institutions.25 Every public institution was
responsible for stewardship, ﬁnancing, and service
delivery only for its particular population. At the same
time, many families relied on the poorly regulated, costly
private sector. Households—even those with social
security—paid for a substantial proportion of their health
care directly, at point of service and out of pocket,
exposing families to impoverishing expenditures.26

As is the case in many countries, regular access to
health care with ﬁnancial protection was oﬀered only to
salaried workers and their families, through social
security mechanisms. The wealthier, formal private
sector received care from the Mexican Institute for Social
Security (IMSS) and the federal public workers from the
Institute for Social Security and Services for Civil
Servants (ISSSTE).26
The non-salaried population (self-employed workers,
the underemployed, the unemployed, those out of the
labour market permanently or temporarily along with
their families) typically accessed health services through
the state Ministry of Health on a public assistance basis.
Health care for this population was funded from
uncertain, residual budget allocations that did not have
explicit entitlements. Care was not comprehensive, and
families paid out-of-pocket, especially for basic services
and medicines.
The decentralisation of services by the federal Ministry
of Health—between 1985 and 2000—devolved to the
states the responsibility of health service delivery for the
uninsured population. However, rules to guide the
2000

2004

2008

2010

Demographic
Total population (millions)

98·4

Population aged younger than 5 years (% of total)

11·6%

10·5%

9·8%

9·4%

4·7%

5·1%

5·6%

6·2%

Population aged 65 years or older (% of total)
Life expectancy at birth (years)
Fertility rate (livebirths per woman)
Population residing in rural areas (%)*

103·0

106·7

112·3

74·0

74·5

75·1

2·4

2·2

2·1

75·4
2·1

25·2%

23·7%

21·9%

23·2%

Socioeconomic
GDP per capita, PPP (constant 2005 international $)†

11 852·7

GDP annual growth (%)‡

6·6%

11 959·3
4·1%

12 892·8

12 440·9

1·2%

5·5%

Gini index§

51·9

46·1

48·3

50·9

Poverty headcount ratio at national poverty line (% of population)¶

53·6%

47·2%

47·7%

51·3%

Poverty headcount ratio at $2 per day (PPP; % of population)

15·1%

7·6%

5·2%

5·7%

Labour force participation rate (% of population aged 15 years or older)||

60·3%

60·6%

61·8%

61·7%

Primary education completion rate, total (% of relevant age group)**

98·0%

99·0%

104·0%

NA

Health
Infant mortality (rate per 1000 livebirths)

18·2

17·6

15·2

14·1

Mortality of children younger than 5 years (deaths per 1000 livebirths)

28·5

20·5

17·9

16·8
10·8

Communicable disease, maternal, perinatal, and nutrition associated mortality (%)

15·4

13·4

11·6

Non-communicable disease mortality (%)

70·7

73·8

75·3

Contraceptive prevalence rate (% of women aged 15–49 years)††

70·0

73·0

72·5

74·8
NA

GDP=gross domestic product. PPP=purchasing power parity. NA=not available. *Population in localities with less than 2500 inhabitants. †GDP converted to international
dollars using PPP rates. ‡Annual percentage growth rate of GDP at market prices based on constant local currency. Aggregates are based on constant US$2000. §Measures
the extent to which the distribution of income or consumption expenditure in individuals or households within an economy deviates from a perfectly equal distribution.
A Gini index of 0 represents perfect equality, whereas an index of 100 implies perfect inequality. ¶Poverty rate measured as the percentage of the population living under the
national patrimony threshold as deﬁned by the National Council for the Evaluation of Social Development Policy (CONEVAL). CONEVAL deﬁnes patrimony poverty as
“insuﬃciency of the income available to acquire the food basket, as well as to make the necessary expenses in health, clothes, housing, transport and education, even if the
entire household’s income was used exclusively for the acquisition of these goods and services”. ||Labour force participation rate is the proportion of the population
aged 15 years and older that is economically active. **Number of new entrants in the last grade of primary education, regardless of age, expressed as percentage of the total
population of the theoretical entrance age to the last grade of primary. This indicator is also known as gross intake rate to the last grade of primary. The ratio can exceed 100%
because of overaged and underaged children who enter primary school late or early, or repeat grades. ††Contraceptive prevalence rate is the percentage of women who are
practising, or whose sexual partners are practising, any form of contraception and is measured for married women ages 15–49 years only. See appendix for data sources.

See Online for appendix

Table 1: Basic demographic, socioeconomic, and health characteristics, Mexico, 2000–10
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Panel 1: Overview of Mexico, 2000–10
The population of Mexico grew from 98 million to 112 million between 2000 and 2010.
In view of the process of demographic transition, fertility decreased and reached near
replacement levels, the proportion of the population aged 5 years or younger fell below
10%, and the elderly population grew from 4·7% to 6·2%.
Overall, health indicators improved steadily throughout the decade. Life expectancy rose
to more than 75 years of age, infant mortality fell from 18·2 to 14·1 deaths per 1000
livebirths, and mortality in children under 5 years old fell from 28·5 to 16·8 deaths per
1000 livebirths.
Mexico has gone through a rapid, polarised, and protracted epidemiological transition.23 The
health burden has shifted towards non-communicable disease and injury that represented
less than a third of mortality in 1950, to 85% in 2000, and to almost 90% in 2010.
Despite the economic crisis of the last part of the decade, gross domestic product (GDP)
per capita grew 5% in real terms. In 2008, the growth rate fell to 1·2% and was negative in
2009 (–6·2%). The proportion of the population living in poverty declined between
2000 and 2010. Still, during interim periods of crisis, poverty increased. The Gini
coeﬃcient similarly improved and then worsened with the crisis.
Recovery from the crisis has been impressive.24 In 2010, GDP growth was up to 5·5% and
reached 3·9% by 2011.
Please see table 1 for basic demographic, socioeconomic, and health characteristics of Mexico, 2000–10.

allocation of federal resources, state ﬁnancial contributions, and state out-of-pocket fees for services provided,
were missing.27
In 1997, IMSS underwent ﬁnancial reform of health
and pensions.28,29 A key tenet was to decrease payroll
contributions and increase reliance on general taxes,
largely to reduce informality. An unintended consequence was increased inequity in the federal allocation
to health care because general tax funds, levied on
all Mexicans, were directed towards the salaried
labour force.
A decade of evidence inspired the Ministry of Health to
focus on the ﬁnancial aspects of reform. In the early
1990s, the ﬁrst national health accounts provided
surprising results: more than 50% of health expenditure
was out of pocket. This result showed overreliance on
ineﬃcient, inequitable, point-of-service funding that
exposed Mexican households, especially the poor and
uninsured, to catastrophic and impoverishing health
expenditures.25,30–32 As a result, Mexico performed poorly
on the fairness of ﬁnancial contribution index of the
World Health Report 2000.33
Although high catastrophic expenditure portrayed
the exclusion of the poor from prepaid insurance and
ﬁnancial protection, families of all income levels, including
those with social security, searched for increased access to
high-quality care. Thus, out-of-pocket was a function of
implicit service rationing through waiting times, medical
drug-shortages, incomplete access to the package of
covered services, and poor quality of care.5 Ironically and
unfortunately, a large part of this spending went to low
quality, unregulated private providers.
1262

In sum, the 2003 reform was largely motivated by
imbalances that necessitated ﬁnancial harmonisation
across public providers. Further, the system before
2003 was characterised by low general health spending;
predominance of private, out-of-pocket spending; unfair
allocation of public resources between the insured and
uninsured, and among states; inequitable state contributions to health ﬁnancing, and underinvestment in
equipment and infrastructure.9 These imbalances, typical
of many low-income and middle-income countries, prevented the health system from responding to the
challenges of ageing and the predominance of costly,
chronic disease and injury.
The creation of the SSPH implied a major legislative
reform focused on ﬁnancial reorganisation to correct
these imbalances. The law, approved by a large majority
of Congress in April 2003, came into eﬀect in 2004.9,34
The overall goal of the 2003 reform was to achieve
universal coverage by including the more than 50 million
Mexicans who had previously been excluded from public,
social insurance. The goal of universal coverage was
grounded in the commitment to increase funding for
health by one percentage point of gross domestic product
(GDP), mainly through public resources. The General
Health Law established a transition period to 2011, later
extended to 2012, to help with a gradual aﬃliation process
and capacity-building to absorb additional resources.
Seguro Popular guaranteed legislated access to an explicit
and comprehensive package of essential services, as well
as more costly, specialised interventions associated with
speciﬁc diseases and health conditions.

Innovations to promote protection for patients and
against health risks
The ﬁnancial reform was complemented with supplystrengthening provisions, including hospital management reform, improved schemes for drug supply,
outcome-oriented information systems, a master plan for
long-run investment in health infrastructure, and
technology assessment.
Emphasis was also placed on public health through
the following instruments: (1) a protected fund for
community services; (2) a set of personal health promotion and disease prevention guides (similar to the
traditional immunisation certiﬁcates) with a gender and
life course perspective; (3) a comprehensive reorganisation
of regulatory activities through a new public health
agency—the Federal Commission for the Protection
against Health Risks (COFEPRIS) charged with safety
and eﬃcacy approvals of new drugs and medical devices,
food safety regulations, enforcement of environmental
and occupational health standards, and control of
marketing of hazardous substances such as alcohol and
tobacco; and (4) major investments in public health to
enhance security through epidemiological surveillance
and improved preparedness to respond to emergencies,
natural disasters, pandemics, and bioterrorism.35
www.thelancet.com Vol 380 October 6, 2012
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The creation of COFEPRIS was key to strengthening
the stewardship role of the Ministry of Health. One
example is the design and implementation of tobaccocontrol measures, including a ban on mass media
advertising, the creation of a General Law on Tobacco
Control and increased tobacco prices. The investments in
epidemiological surveillance, state laboratories and
preparedness were crucial in confronting the 2009 H1N1
inﬂuenza crisis.36,37
Another crucial element to strengthen stewardship was
the expansion of the role of the General Health Council
(Consejo de Salubridad General), a collective decisionmaking body that spans all participants in the health
sector and whose leadership requires Presidential
appointment. The Council was charged with deﬁning
and updating the package of covered high-cost interventions, certiﬁcation of health-care providers, and more
recently, with the design of strategies to prevent noncommunicable disease.38
To reinforce patient protection, the central programme
of the managerial reform was the National Crusade for
Quality in Health Care. The purpose of this programme
was to enhance patient safety, improve responsiveness,
manage facility accreditation and provider certiﬁcation,
implement quality improvement initiatives, measure
technical and interpersonal quality, and undertake
performance benchmarking among states and other
organisations.39
Another important innovation was the creation of
the National Center for Health Technology Excellence
(CENETEC) in 2004. This Centre produces information
and enables an evidence-based approach for investment and use of medical technologies, and coordinates
the development of clinical practice guidelines. It has
achieved international recognition and is a WHO
collaborating centre.

Innovations to promote ﬁnancial protection
Key to the ﬁnancial innovations introduced by the SSPH
is the separation of funding between personal health
services and health-related public goods (including nonpersonal health services).40 The separation is designed to
protect public health services, which tend to be at risk in
reforms that expand insurance.41
Funds are aggregated over the population without
access to social security and divided into four components: (1) stewardship, information, research, and
development; (2) community health services; (3) essential personal or clinical health services; and (4) high-cost,
catastrophic health interventions (table 2).
The regular budget of the Ministry of Health ﬁnances
stewardship functions, research, dissemination of information, and human resource development. The Fund for
Community Health Services covers health promotion,
immunisation campaigns, primary prevention, early
detection, epidemiological surveillance, and control and
risk protection activities. To avoid erosion of funding as
www.thelancet.com Vol 380 October 6, 2012

reform proceeds, the services covered are explicitly
deﬁned and expand from year-to-year, although funding
is subject to annual budgetary negotiation.
Funding for personal or clinical services, by contrast, is
based on a public insurance logic focusing on risk pooling,
prepaid contributions according to capacity to pay,
progressive subsidies provided through public funding
from general taxation, and explicit entitlement to a package
of health interventions.21 The instrument devised by the
reform to ﬁnance these services is the Seguro Popular.
Explicit entitlement to a package of speciﬁc services is a
milestone. The ﬁnancial resources behind the insurance
scheme are divided between a package of essential
interventions provided in ambulatory settings and
general hospitals ﬁnanced through the Fund for Personal
Health Services (FPHS), and a package of high-cost,
specialised interventions that are available only through
specialised providers and ﬁnanced through the Fund for
Protection against Catastrophic Health Expenditures
(FPCHE; panel 2).10 More recently, a set of interventions
speciﬁcally addressing children and newborn babies,
including new vaccines, were added through the Medical
Insurance for a New Generation (Seguro Médico para una
Nueva Generación).
Diﬀerences in health or socioeconomic status are
not taken into consideration and pre-existing condition
clauses are forbidden in the enrolment process. This
eliminates risk selection based on health needs. As
stipulated by law, the essential and high-cost intervention
packages must be progressively expanded.45 As funding
increased, it became possible to combine horizontal
coverage of a growing number of beneﬁciaries with vertical
expansion of the interventions and entitlements (ﬁgure 2).
The ﬁnancial architecture of Seguro Popular was
designed to increase equity in the application of federal
funds between populations with and without social
security. It was harmonised with the IMSS, guided by
the 1997 reform.46 In 2007, the ISSSTE was also
reformed and restructured along similar lines. As a
result, allocations are similar across all three agencies,
paving the way for the creation of a single health fund
and payer scheme.
Fund
Public goods
Stewardship

Regular budget of the Ministry of Health

Information, research, and human resource development

Regular budget of the Ministry of Health

Community health services

Fund for Community Health Services

Personal health services
Essential health-care services (Seguro Popular)

Fund for Personal Health Services

Health-care services for children and newborns

Medical Insurance for a New Generation*

Specialised and high-cost services

Fund for Protection against Catastrophic
Health Expenditure

Adapted from Frenk J and colleagues.9 See appendix for data sources. *As of December, 2006.

Table 2: Funds of the System for Social Protection in Health by type of health good
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Panel 2: Financial coverage and service delivery of catastrophic interventions
The System of Social Protection in Health (SSPH) covers costly, specialised interventions
through the Fund for Protection against Catastrophic Health Expenditures (FPCHE) using
8% of all resources annually allocated to Seguro Popular, which can be supplemented
through earmarked contributions. These resources are administered through a trust
managed at the federal level by the National Commission for Social Protection of Health
(NCSPH), the agency responsible for the implementation and operation of Seguro Popular.
Interventions subject to coverage are drawn from a list of interventions previously
identiﬁed by the General Health Council as those likely to be ﬁnancially catastrophic for
the individual patient. The National Comission reimburses providers using preset tariﬀs
for every intervention. Only interventions explicitly covered by the fund and delivered by
certiﬁed providers are amenable to reimbursement.
The growing evolution and operational complexity of FPCHE is portrayed in the number of
covered interventions and the caseload. The annual budgetary allocation to FPCHE has
increased more than 12-fold between 2004 and 2011 as the number of enrollees grew. In
2011, the resources allocated to this fund amounted to US$700 million and is increasing.42–44
In 2004, only six interventions related to four diseases (HIV/AIDS, cervical cancer, acute
lymphoblastic leukaemia in children and adolescents, and cataract surgery) were covered,
and by the end of 2011 the ﬁgure had reached 57 interventions with a further expansion
planned in 2012. Interventions currently covered are associated with a growing set of
diseases and health disorders including among others all childhood, breast, prostate, and
testicular cancers, corneal transplantation, acute myocardial infarction in adults younger
than 60 years, and congenital and acquired malformations amenable to surgery. The total
number of reimbursed cases per year increased from 2661 in 2004 to 172 945 in 2011.42,44 In
2011, the largest budget shares corresponded to HIV antiretrovirals (about 40%), breast
cancer (close to 25%), and neonatal intensive care (about 15%).44

Like IMSS and ISSSTE, Seguro Popular ﬁnancing is
tripartite. In the absence of an employer, ﬁnancial coresponsibility is between the federal and state governments. A social contribution is provided by the federal
government and was just under US$70 (MXN847) in
2011. The federal and state governments each provide
a solidarity contribution. On average, the federal
solidarity contribution is 1·5 times, whereas the mandated state contribution is 50%, of the social contribution per enrollee. In principal, the aﬃliate also
contributes as a function of income. The law exempts
low-income households—originally the two poorest
and later the four poorest income deciles as well as
families in deciles IV–VII that include a pregnant
woman or a young child.
Funding for states is demand-driven as it is determined
largely by Seguro Popular enrolment. The federal
contribution is allotted to states by use of a formula based
on enrolled individuals, health needs, and performance.
The legally-mandated formula was a major innovation
over previous inertial, subjective budgeting that was
often driven by political negotiations.
Enrolment of most hard-to-reach, poorer segments of
the population in both rural and urban areas was helped
by the existence of Oportunidades, a large-scale social
programme based on conditional cash transfers.8
Oportunidades, initiated in 1997, now covers 5·8 million
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families—most of the poor.47 Further, states have
the incentive to enrol the entire population to expand
their budget.

Implementation of the Mexican health reform
Health system reforms are not linear processes. As has
been the case in Mexico, continuous evidence-based
policy reformulation stimulates and guides implementation. For example, MING, launched in December,
2006, was a focal programme of the Government of
President Felipe Calderón and an endorsement of Seguro
Popular. MING provided an eﬀective, as well as politically
salient, instrument to grow the SSPH.
MING wove new opportunities into the tapestry of
covered beneﬁts and beneﬁciaries as an important
complement to FPCHE and Seguro Popular. Whereas the
FPCHE was based on accelerated coverage for speciﬁc
diseases and interventions, and the Seguro Popular was a
gradual horizontal expansion of coverage by population
group, MING used both platforms in a diagonal approach.
MING brought additional funding that allowed for the
expansion of the catastrophic fund for newborn babies
and children younger than 5 years, and accelerated
coverage of Seguro Popular for their families. In 2007,
110 interventions for newborn babies were added. As of
2012, the programme covers 131 additional interventions
and has grown six times to cover 5·95 million children
(ﬁgure 2). MING has been reinforced by targeted
education and awareness-building on issues such as
breast feeding and early childhood stimulation. Funding
provided by MING was essential for the universalisation
of rotavirus and Pneumococcal conjugate vaccines.
Another critical update was the reformulation of the
Seguro Popular reimbursement unit from the family to
the individual. Until 2010, the deﬁnition of the family
unit included the head of the household, the spouse or
partner, dependent children (younger than 18 years,
studying, or disabled), and parents older than 64 years.
This deﬁnition of the family unit allowed for the
registration of individuals older than 18 years within the
same household as single-person family units. Evidence
showed a larger than expected number of single-person
and small families being enrolled.48 In some cases,
gaming by states split families living in the same
household to increase enrollees and consequently the
transfer of federal resources, putting at risk the overall
ﬁnancial health of the Seguro Popular.
At the same time, ﬁnancing for the reform was
calculated on the basis of an average nuclear family size
of 4·3 members, which did not capture continuous
declines or variance in family size across states. As a
result, the allocation per person was larger for wealthier
states where the average family size is smaller than in
poorer states, contributing to inequities.49
The ﬁnancing unit was redeﬁned in 2010 through a
modiﬁcation of the General Health Law from a family to a
capitation fee per enrolled individual. Under the revised
www.thelancet.com Vol 380 October 6, 2012
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Law, the rhythm of enrolment gained momentum.50 A
special compensatory fund was established to allow for
transition for states where the new reimbursement rules
required large budgetary adjustments.
Yet, universal health coverage proved unattainable in
2010. This was partly because of the economic crisis and
the H1N1 epidemic, which redirected funds allocated for
Seguro Popular expansion into purchase the ﬂu vaccine
and antiviral drugs, as well as to support other measures
to deal with the epidemic.” Additional challenges
included increasingly diﬃcult to enrol population groups
(eg, high-income individuals), and poor supply capacity,
especially in rural settings. As a result, the timeline and
budget to achieve universal coverage was extended from
December, 2010, to December, 2011.50
Another major adjustment was the implementation
of expenditure controls for states. The 32 state
governments are responsible for spending 89% of total
resources of the Seguro Popular to ﬁnance the delivery
of the essential package of health interventions.
Agreements signed between the federal government
and every state set clear rules on the annual transfer
and allocation of resources.
Because of the high degree of heterogeneity in the use
of resources across states,51 since 2008, regulations for the
use of federal resources and the annual service agreements
limit expenditures by item. States can spend a maximum
of 40% of total federal allocation on personnel, and 30%
on medicines, materials, and other inputs.
It also proved necessary to regulate the purchase prices
of medicines as there were large variations for both
generics and patented drugs that could not be explained
by local market conditions or volumes tendered.52 This
prompted greater monitoring of purchasing, integration
of information, and the design of better guidelines for
the eﬃcient procurement of medicines by the states.
Reference prices were established and states cannot
purchase drugs with federal funds at prices more than
20% above this level. For on-patent drugs, states can
beneﬁt from federally negotiated prices that aggregate
the federal Ministry of Health, IMSS, and ISSSTE.
However, some states still purchase at prices well above
the reference suggesting the need for further
improvement in drug purchasing mechanisms.53
Coresponsibility—exercising rights while complying
with obligations—is a key element of the Mexican
reform. In the initial design of the reform, the main
instrument for coresponsibility was family coﬁnancing.
As enrolment progressed, it became evident that only a
few enrollees—about 1% of families by the end of
2011—were paying the family premium.44
A new modality of coresponsibility was introduced
through health promotion and a strategy of wellness
check-ups. Consulta Segura is an integral part of the
Mexican government’s response to increase immunisation coverage and deal with major risk factors
including unhealthy behaviour (tobacco and alcohol use),
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Figure 2: Evolution of vertical coverage: cumulative number of interventions covered by the Seguro Popular,
the Fund for Protection against Catastrophic Health Expenditure, the Fund for Community Health Services,
and the Medical Insurance for a New Generation, 2004–12
See appendix for a full list of data sources. MING=Medical Insurance for a New Generation (children born after
Dec 1, 2006, and until they are 5 years old). FPCHE=Fund for Protection against Catastrophic Health
Expenditures. EPHS=Essential Personal Health Services. EPI=Expanded Programme of Immunisations.
CBP=Community-based package.

obesity, and high blood pressure, and thus, to prevent
chronic and catastrophic illness.54
The check-up is compulsory for any person at the time
of enrolment or re-enrolment and hence encourages
beneﬁciaries to invest in their own health maintenance.
It is designed to take 10 min and is integrated into the
enrolment process, which typically takes place at a local
hospital or clinics where modules have been set up.
The objective of this strategy is to build a risk proﬁle of
every beneﬁciary, promote a shift from curative to
preventive care, and generate a registry and a system for
early detection. The strategy has four components: a
privacy-protected, ﬁngerprint registry of all beneﬁciaries
aged 10 years and older; basic screening for health risks;
targeted medical care in response to the results of the
check-up; and an integrated health information system
useful for the development of future electronic health
records. Consulta Segura has expanded rapidly and since
2010, more than 11 million individuals have been registered
and almost 5 million screenings have been done.
Budgetary provisions for primary prevention have also
been reinforced. As of 2008, annual budgets force the
states to invest 20% of all Seguro Popular funds on
prevention. This complements the federally-run community health fund.54

Eﬀects of the Mexican health reform
This section discusses the eﬀects of the reform on
structural and process indicators including labour
1265

Health Policy

markets, economic development, and ﬁnance; followed
by an examination of eﬀective coverage, health status,
responsiveness, and ﬁnancial protection.55 Evidence from
published research and recently collected data by the
Mexican Government are presented (panel 3).

Availability, distribution, and allocation of ﬁnancial
resources
National health accounts suggest improvement in
ﬁnancial imbalances (table 3). Total health expenditure
grew from 4·4% of GDP in 1990 to 5·1% in 2000, and to
6·3% in 2010.65 Total health expenditure per person
increased from US$ purchasing power parity (US$ppp)
508 in 2000 to US$ppp 959 in 2010, while government per
capita health expenditure increased from US$ppp 237 in
2000 to US$ppp 469.

Panel 3: Bibliometric analysis and databases
To document the progress in the intrinsic and instrumental goals of the Seguro Popular, we
searched Medline, PubMed, and Google Scholar with keywords “Seguro Popular”, “System
for Social Protection of Health”, and “Seguro Popular and health”. This search uncovered
533 documents. In a second ﬁlter, we added “Mexico” and “eﬀects” and/or “impact”,
reﬁning the list to 184 documents. Although some work remains unpublished, 83 articles
are available in peer-reviewed journals, of which 27 are international and 56 Mexican.
We further classiﬁed the 58 documents that analysed the eﬀects or impact of the Seguro
Popular using the WHO 2000 framework for health system performance.33 Seven studies
were devoted to the impact on health conditions, four to responsiveness, and ten to
ﬁnancial protection. Further, three reviewed the eﬀects on stewardship, 11 on ﬁnancing,
three on resource generation, 14 on inputs and services, and another six on other sectors,
speciﬁcally the labour market.
Additionally, we accessed several databases either directly or through published
information used in regular administrative evaluations published by the Ministry of
Health. These databases include the National Household Income and Expenditure Surveys
(Encuesta de Ingresos y Gastos de los Hogares),56 the National Survey of Demographic
Dynamics (Encuesta Nacional de la Dinámica Demográﬁca; ENADID),57 and the National
Survey of Health and Nutrition (Encuesta Nacional de Salud y Nutrition; ENSANut).58 For
the National Survey of Health and Nutrition, we reviewed the 2000, 2006, and
2012 surveys, although for the 2012 survey, only national-level estimates were available
because the survey was recent.
We also analysed data from administrative reports and evaluations undertaken by the
Ministry of Health. These data included a third round of evaluation of the Seguro Popular
published only in Ministry of Health reports,59 that served as a partial (due to sample
attrition issues) follow-up to the experimental evaluation undertaken in 2005–06.60
Most studies and data available provide descriptive results. Further, some of the data are
only available at the national level and overall improvement cannot be exclusively
assigned to Seguro Popular. Although not recent and spanning only 11 months of the
coverage of the Seguro Popular, the 2005–06 experimental evaluation does allow for
causal interpretation.60 Further, several studies have been produced that use econometric
techniques to analyse outcomes and causality.61–64
The availability of data, and particularly the ENSANut 2012, should spawn a new cadre of
studies. Further, a new round of the 2005–06 evaluation, combined with more detailed
econometric analysis of the 2008 evaluation follow-up,59 could eﬀectively shed light on
the progress of the Seguro Popular.
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Gaps between public and private expenditure are just
beginning to close. Public spending as a percentage of
total health expenditure increased from 46·6% in 2000 to
48·9% in 2010.65
Additional public resources have been mainly
allocated to institutions caring for the previously
uninsured. Between 2000 and 2010, the Ministry of
Health budget increased 142% in real terms whereas
the budget of IMSS grew 42% and that of ISSSTE 103%.
This narrowed gaps between Mexicans with access to
social security and those without and the ratio of per
capita public expenditure declined from 2·1 in 2000 to
1·2 in 2010.66,67
The allocation of federal resources across states also
improved. In 2000, the diﬀerence between the state
receiving the greatest allocation of federal resources per
person and the state least favoured was 6·1 to 1. By 2010,
this diﬀerence was 3 to 1 (table 3). Variations in state
contributions to ﬁnancing declined somewhat, as shown
by the small drop in the coeﬃcient of variation between
2000 and 2010.68 Further, the share of total public
expenditure ﬁnanced by the states has been increasing
slowly but consistently since the creation of Seguro
Popular.69 Finally, resources devoted to investment
increased in absolute terms. As a proportion of the
Ministry of Health budget, investment grew from 3·3%
in 2000 to 4·4% in 2010.70

Labour markets and economic development
One concern about Seguro Popular is stimulating parts
of the labour force that evade taxation and social security
contributions, and thus risking long run economic
growth. Reviews of this issue suggest that the materialised risk is small and the concern misformulated.15
Conceptually, non-salaried work has been erroneously
considered equivalent to informality, which in turn has
typically been synonymous with active evasion of the
formal sector, salaried employment and taxation.71
Seguro Popular targets all non-salaried workers who
cannot access social security because they do not have
an employer. This group is much larger and not
coincident with informality. It includes independent
workers, professionals and agricultural labourers, as
well as those who do not participate in the labour force
(ie, homemakers and elderly people).15
Empirically, most papers show the eﬀect to date of
Seguro Popular on salaried and formal employment is
either nonexistent, small, or restricted to speciﬁc
population subgroups.72–78 Only two of the nine studies
found a relatively small, negative eﬀect on enrolment in
social security.79,80 Further, movement is not out of
salaried employment but rather into non-salaried work.
Measuring the outcome of Seguro Popular requires a
longer term, causal analysis. Seguro Popular was
developed as a response to structural inequity and
ineﬃciencies that prevailed in the Mexican health system
and were already aﬀecting labour markets. Indeed, an
www.thelancet.com Vol 380 October 6, 2012
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Coverage of public health insurance improved substantially between 2002 and 2011. Seguro Popular enrollees
reached 52·6 million in April, 2012 (ﬁgure 3). Most
belong to the poorest four income deciles, 35% reside in
rural communities (compared with 22% nationally), and
close to 9% belong to indigenous communities (compared with 6% nationally).44,87
In 2002, over 60 million Mexicans did not have any
institutional form of ﬁnancial protection in health.
Although substantial debate concerning total coverage
numbers exists, particularly for IMSS, a conservative
estimate of the total number of Mexicans who had
health insurance in 2002 is 41·5 million (38·7 million
through social security and 1·8 million exclusively by
private insurance).88,89 By 2010, social security had
increased to 59·2 million, and Seguro Popular enrolment
reached 43·5 million.44,90 An additional 8·3 million
people enrolled in Seguro Popular in 2011. Thus,
accounting for duplicate coverage between insurance
schemes, about 110 million—almost 98% of Mexican
residents—were registered with a health insurance
entity by the end of 2011.87 Further, the Ministry of
Health 2012 budget is suﬃcient to ensure that all who
do not have access to social security, taking into account
population growth, can be aﬃliated voluntarily to Seguro
Popular. Thus, as of 2012, Mexico is on track with
universal coverage.
Both enrolment and the number of covered interventions in each package have expanded continuously
(ﬁgure 2 and panel 2). The package of essential services,
for example, grew from 91 interventions in 2004, to
284 in 2012, covering treatment for more than 95% of
causes in ambulatory units and general hospitals.
www.thelancet.com Vol 380 October 6, 2012
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Health expenditure as percentage of GDP
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Out-of-pocket health expenditure as percentage of
total health expenditure

Distribution

Ratio of per-person public expenditure between
those covered by social security agencies and those
without social security

2·1 to 1·0

2·1 to 1·0

1·2 to 1·0

Distribution

Ratio of federal per-head expenditure on health in
the state with the highest ﬁgure to that in the lowest

6·1 to 1·0

4·3 to 1·0
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State
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Variability in state contribution to health-care
ﬁnancing (coeﬃcient of variation)
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0·7

Allocation of
funds

Percentage of MoH budget devoted to investment

3·3%

3·1%
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See appendix for data sources. GDP=gross domestic product. MoH=Ministry of Health.

Table 3: Evolution of ﬁnancial imbalances in the health sector, Mexico 2000–10
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objective of the 1997 reform of IMSS was reducing
informality. Meta-analysis suggests that future research
and policy questions, given the many positive eﬀects of
Seguro Popular, should consider how to minimise labour
market eﬀects. This includes focusing on improving the
eﬀectiveness of IMSS.81
From an ethical perspective, to deny access to health
care on the basis of type or absence of employment is
indefensible. It is also unnecessary. Numerous policy
instruments to stimulate salaried employment can be
disassociated from health care. Indeed, labour market
performance is largely deﬁned by policies outside of
health, such as overregulation.82
A longer-term approach is required to conceptualise
and eventually measure the full impact of Seguro Popular
on labour markets and economic development. Investment in health can stimulate productivity and catalyse
investments in education.83–86 Although it is too early to
measure the full eﬀect of Seguro Popular on labour
market productivity and economic growth through
improved health, this eﬀect is likely to overwhelm small,
short-run implications for informality.
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Figure 3: Evolution of enrolment to Seguro Popular, Mexico 2004–12
See appendix for a full list of data sources.

Health infrastructure, human resources, and availability
of drugs
Health infrastructure—both of Ministry of Health and
social security—grew over the decade. Between 2001 and
2011, 15 high-specialty centres were built as were more
than 200 hospitals and almost 2000 ambulatory clinics.91,92
Additionally, more than 4000 facilities were renovated or
equipped.
Additional personnel were hired with Seguro Popular
resources.93 The physician (general and specialist) to
population ratio increased by 54% between 2004 and
2010, compared with 7% between 2000 and 2004. Further,
the availability of nurses increased by 29% between
2004 and 2009, compared with a 1% decrease between
2000 and 2004.52,94,95
Still, the expansion of the human resource base
remains a challenge, especially in a decentralised health
system. Most new personnel were initially hired by
states with variable, short-term contracts. The situation
improved as contract terms lengthened, legally-mandated
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beneﬁts were introduced, and salaries were standardised.52 Initial imbalances created by over-hiring administrative staﬀ have been largely corrected.
Seguro Popular ﬁnancing has also been channelled
into access to essential drugs. In 2002, 55% of patients
reported prescriptions in ambulatory clinics of the
Ministry of Health as fully ﬁlled.96 In 2011, this number
reached 62%.97 For social security institutions, the
proportion of prescriptions correctly and completed ﬁlled
also increased over the same period (from 70% to 87%).98

Use of health services
Based on the 2006 ENSANut, Seguro Popular enrollees had
a higher probability of service use, conditional on perceived
need, than did uninsured individuals.13,99 The 2006 National
Satisfaction and Responsiveness Survey done in
74 hospitals nationwide showed that Seguro Popular
enrollees had a higher probability of using hospital services
for elective surgeries, diabetes, and hypertension than did
the uninsured.100 Another study showed an increase in the
probability of visiting a health unit.61
Use of health services for childbirth between 2000 and
2012 provides additional support. The proportion of
births in private entities declined from 25% to 19%, and
in social security facilities from 35% to 26%. By contrast,
use of public, Ministry of Health facilities increased from
32% to 48% (ﬁgure 4).
By contrast, the short-term, 2005–06 assessment60
showed no measurable eﬀect on service use. Still, in
the follow-up assessment for 2008, Seguro Popular
households registered 3·3 health visits per year, which
was signiﬁcantly higher than the visits registered by
non-Seguro Popular households and similar to social
security.59,101

Impact on eﬀective coverage and health conditions
Both maternal and child mortality continue to decline.
From 1990, the baseline year for the Millennium
Development Goals (MDGs), mortality in children
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Figure 4: Childbirth by type of care facility, Mexico 2000–12
Estimated by the authors on the basis of original data sources cited in the appendix.
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younger than 5 years fell from 47·1 per 1000 livebirths to
16·7 in 2010.69 Projections indicate that Mexico will meet
the MDG 4 target before 2015.102,103
Interventions to reduce maternal mortality are targeted
to MDGs 4 and 5. Fair Start in Life, a national programme
launched in 2001, includes a safe motherhood component
that strengthens care networks and inputs, most notably,
a safe supply of blood. Special measures were
implemented to expand coverage of antenatal care and
access to institutional deliveries, with emphasis on
timely diagnosis, high-risk pregnancies, and emergency
responses. Closer monitoring and detailed review of
maternal deaths through verbal autopsies were implemented. Maternal mortality numbers declined substantially from 90·4 per 100 000 livebirths in 1990 to 51·5 in
2010, yet meeting MDG 5 will require further reductions
that are especially challenging to achieve.
Improvements in maternal mortality and in mortality
in children younger than 5 years have been larger for
the previously uninsured than for social security
beneﬁciaries. Mortality in children younger than 5 years
fell by 11% for the population without social security
compared with 5% for those with access. Maternal
mortality fell by 32% for those without social security
compared with 3% for those with access (table 4).
Coverage and eﬀective coverage (when measurable)3
have increased. Between 2000 and 2006 coverage for
prenatal care and childbirth, immunisation (BCG
[Bacillus Calmette–Guérin], DPT [diphtheria, pertussis,
and tetanus], and measles vaccines), care of premature
newborn babies, treatment of diarrhoea and acute
respiratory infections in children, mammography,
cervical cancer screening, and treatment of hypertension
improved, concentrated in the poorest states and income
deciles.11,104
With a composite indicator of interventions, in
2006 Seguro Popular enrollees had signiﬁcantly higher
levels of coverage than did the uninsured.13 Further,
individuals with social security had signiﬁcantly higher
composite coverage than the uninsured in 2000, but by
2006, the diﬀerences with Seguro Popular enrollees were
insigniﬁcant. Controlling for observable diﬀerences,
Seguro Popular enrollees had signiﬁcantly more coverage
than the uninsured for hypertension treatment,
mammography, cervical cancer screening and acute
respiratory infections in children. For interventions
covered in long-standing national programmes (ie,
childhood immunisations) the diﬀerences were, as
expected, insigniﬁcant.
ENSANut data from 2006 and 2012 show further
improvement (table 5). Coverage for measles and BCG
has remained high and close to the same level (90·1% for
measles and 97·1% for BCG), and has increased a few
points for DTP3 (88%). Diarrhoea treatment has
increased slightly and encouraging and signiﬁcant
improvements exist in coverage of acute respiratory
infections in children younger than 5 years.
www.thelancet.com Vol 380 October 6, 2012
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2004

2010

Percentage of change

Social
Non-social Gap†
security* (a) security* (b) (c=a/b)

Social
Non-social Gap†
security* (d) security* (e) (f=d/e)

Social security*
Non-social security*
(g=([d/a]–1)×100) (h=([e/b]–1)×100)

Health conditions: mortality
Deaths in children younger than 5 years (per 1000 livebirths)

12·8

25·0

0·5

12·1

22·3

0·5

–5·2

–11·0

Maternal deaths (per 100 000 livebirths)

28·7

72·2

0·4

27·9

48·9

0·6

–2·9

–32·3

Financial protection
Out-of pocket health expenditure by households as a proportion of
total income (%)

3·0%

4·4%

0·7

2·6%

3·2%

0·8

–14·2%

–27·6%

Out-of pocket health expenditure by households as a proportion of
disposable income (%)

3·7%

5·9%

0·6

3·3%

4·6%

0·7

–10·8%

–21·9%

Percentage of households with catastrophic health expenditures

1·5%

3·6%

0·4

1·4%

2·8%

0·5

–10·0%

–20·6%

Percentage of households with impoverishing health expenditures

0·2%

2·1%

0·1

0·1%

1·6%

0·1

–51·9%

–25·0%

Estimated by the authors on the basis of original data sources cited in the appendix.*Social security refers to the population covered by social security institutions, while non-social security refers to the
population without access to health care through social security institutions, that is the previously uninsured population targeted by the Seguro Popular. †Gaps shown correspond to the ratio of the value
observed for the insured by social security divided by the corresponding value for the previously uninsured; they are read as the number of times the value for those insured by social security exceeds the value for
the previously unsinsured. The closer to one, the greater equality between population groups.

Table 4: Progress in closing the gaps between population groups, health conditions, and ﬁnancial protection

Skilled birth attendance reached 94·9% in 2006, and
94·4% in 2009, according to the national demographic
survey of 2009 (Encuesta Nacional de la Dinámica
Demográﬁca; ENADID).11,105 The ENSANut shows that
rates continue to be close to 92%, and suggests a major
improvement in coverage of prenatal care from 67·3% in
2006 to 81·3% in 2012 (table 5; panel 4).
Progress has been made in prevention, early detection,
and treatment of cervical cancer, although the poorer,
southern states continue to have higher incidence and
death rates than the richer.109–111 Screening coverage
increased from 30% in 2000 to 43·8% in 2006, and 48·5%
in 2012 (table 5).13 Additional to traditional cytological
examinations, in 2008, the Ministry of Health introduced
tests to identify human papillomavirus DNA sequences.69
Further, between 2008 and 2010, the human papillomavirus vaccine was applied for the ﬁrst time to teenage
girls in the 125 poorest municipalities. As of 2012, the
vaccine is being applied to all 9-year-old Mexican girls.
Access to breast cancer treatment shows promising
signs of improvement. By 2010, FPCHE was ﬁnancing
treatment for more than 17 000 women.112 National data
are unavailable, but the numbers from the largest, public
specialty cancer centre, the National Institute of Cancer
of Mexico, indicate that adherence increased.110 In 2005,
about 30% of the 600 women diagnosed with breast
cancer abandoned treatment within a year. In 2010, less
than 1% of 900 women abandoned treatment.113 The
package of covered services is broad—trastuzumab for
example, was included in 2008.114 Still, most patients with
breast cancer begin treatment at advanced stages.
ENSANut data show that screening rates have remained
constant at about 20%.
Seguro Popular funding for childhood cancer is
channelled to drug access, regional centres of excellence,
and paediatric oncology training. Abandonment of treatment has declined to 5% (from about a third between
www.thelancet.com Vol 380 October 6, 2012

Measles immunisation in children (18 months and 59 months)

2006

2012

Diﬀerence
–1·9*

92·0

90·1

DTP3 immunisation in children between (18 months and 59 months) 85·6

88·0

Bacillus Calmette–Guérin (BCG) immunisation in children younger
than 5 years

97·8

97·1

–0·6

Antenatal care

69·1

81·3

14·0*

Skilled birth attendance

94·9

91·8

–1·5

Treatment of acute respiratory infections in children younger than
5 years

58·1

63·8

Treatment of diarrhoea in children younger than 5 years†

59·2

61·3

Breast cancer screening in women aged 40–69 years (mammography) 21·6

20·1

Cervical cancer screening in women aged 25–64 years

48·5

43·8

2·4*

5·7*
2·1*
–1·5
7·3*

Estimated by the authors on the basis of original data sources cited in the appendix. *Signiﬁcant diﬀerences. †The
indicator diﬀers from Lozano and colleagues11 since it is restricted to include packaged oral rehydration therapies only.

Table 5: Coverage of speciﬁc health-care interventions, Mexico, National Surveys of Health and Nutrition
(ENSANut) 2006 and 2012

2000 and 2005), and 30-month survival rates for acute
lymphoblastic leukaemia—covered since 2005—have
increased to over 60% in several of the accredited hospitals.
Still, the variance in outcomes across hospitals indicates
opportunities for improvement as capacity is built.115,116
Between 2000 and 2006, hypertensive and diabetic adults
with Seguro Popular had a signiﬁcantly higher probability
of receiving treatment than did the uninsured.62,63
Furthermore, Seguro Popular beneﬁciaries with diabetes
showed better blood glucose levels.63 These data show
important improvement over the period of the reform.
Although causality cannot be inferred from the available
data on mortality and coverage, a likely association with
the expansion of Seguro Popular merits further research.

Responsiveness
In the 2005–06 Seguro Popular assessment,60 69·8% of
Seguro Popular enrollees rated health services received as
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Panel 4: Dynamic, eﬀective universal health coverage: expanded immunisation and
investment in child health
In 1989, a measles epidemic started in Canada, and eventually reached Mexico.
Consequences were fatal in malnourished Mexican populations. In the USA, 120 of
55 000 reported cases died. In Mexico, more than 6000 children younger than 5 years
died, concentrated in the poorest, southern states.14
The prevailing wisdom suggested that one dose of measles vaccine was enough for
lifelong protection and that 80% vaccination coverage in the child population would
prevent outbreaks. Further, administrative records in Mexico were overestimating
eﬀective coverage and providing a false sense of security.
This epidemic spurred the coinage of the term “immunological equity”, which was to be
achieved through a universal vaccination programme whose audacious goal was “all the
children; all the vaccines” by October, 1992.
Polio and measles were eliminated. Major public health interventions available at that
time—vaccines, vitamin A, albendazole, oral rehydration therapy—have been delivered
since then three times a year to all children and communities.
This public health policy has been expanded by successive administrations, leading to
measurable improvements in the health and nutrition of Mexican children.14 Further, an
integrated set of platforms now exist with a prochild focus that include nationwide,
conditional cash transfer programmes such as Oportunidades, which has had measurable
eﬀects on child development.106,107
Since the 2003 reform, the immunisation package has been expanded and now contains
12 vaccines, including those for rotavirus, pneumococcus, and human papillomavirus. As
of 2011, two doses of human papillomavirus vaccine were included in the Seguro Popular
for girls.
The implementation of the Seguro Popular has resulted in a comprehensive investment by
Mexico in child health, which since December of 2006, includes a broad range of
treatments and services. All newborns are covered by the programme through Medical
Insurance for a New Generation. Indeed, spending through Seguro Popular on children
below the age of 16 increased from $US12 million in 2007 to $102·6 million in 2011, and
the number of covered children from about 800 000 to 5·8 million.108
8

Catastrophic or impoverishing, or both
Impoverishing
Catastrophic

Proportion of households (%)

7
6
5
4
3
2
1
0
Percent at risk
Catastrophic or
impoverishing, or both
Impoverishing
Catastrophic

1992

1994

1996

1998

6·0
4·2
2·8

6·7
4·5
3·3

6·7
4·5
3·3

6·7
4·5
3·5

2000
2002
Year
5·5
3·3
3·1

4·3
2·2
2·7

2004

2006

2008

2010

3·6
1·3
2·7

4·5
1·5
3·5

3·1
1·0
2·4

2·6
0·8
2·0

Figure 5: Trends of catastrophic and impoverishing health expenditure in Mexico, 1992–2010*
Estimated by the authors on the basis of original data sources cited in the appendix. *Catastrophic expenditure is
measured as 30% or more of capacity to pay in turn proxied by total household expenditure less spending on food.
Impoverishment is measured as households falling below the poverty line equivalent to $1 purchasing power
parity, or deepening impoverishment if below the poverty line.
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very good or good, 85% reported that beneﬁts were well
communicated, 94% that they were well treated, and 97%
planned to re-enrol.60
The Ministry of Health is legally obligated to undertake
nationally representative surveys of users of Seguro
Popular. In 2011, 97% of the roughly 22 000 people
interviewed with health facility exit poll surveys reported
satisfaction with services received and more than 95%
praised the interpersonal quality and ease of making
appointments. Almost all (99%) reported that they would
re-enrol, 30% because they did not have to pay fees at
time of service, and 24% because of quality of care.117
Comparing 2004 and 2011, perception of primary care
treatment improved slightly as did the access to
information from the primary care physician.117 Waiting
times in outpatient services decreased, but increased in
emergency wards.118
Similarly, ENSANut show improvements between
2006 and 2012 in perception of care as good or very good.
The number increased from 79·1% to 84·6%.
Certiﬁcation and accreditation have expanded and
9592 of 12 743 units became accredited between 2004 and
2010. This helps patients to identify high-quality services.119
Independent regional initiatives have also been collecting information. Latinobarómetro considered Seguro
Popular the most beneﬁcial public policy implemented in
Mexico in that period.120

Financial protection
Evidence shows signiﬁcant progress in reduction of
catastrophic health expenditure (CHE, 30% of capacity to
pay) and impoverishing health expenditure (IHE, households forced below or further below a poverty line).
Catastrophic and impoverishing health-care payments
from 1992 to 2010 show a long-run downward trend
(ﬁgure 5).12,121 In 2000, 3·1% of households had CHE and
3·3% had IHE. By 2010, the values had dropped to 2%
for CHE and 0·8% for IHE.
Furthermore, the diﬀerences between households
with and without social security are decreasing (table 4).
The diﬀerential share of out-of-pocket spending in
household income and CHE fell for all groups between
2004 and 2010, especially for families without social
security. IHE fell from 0·2% to 0·1% for households
with social security, and from 2·1% to 1·6% for the rest
of the population.
Notably, the drop in CHE is evident despite the small
reduction in levels of out-of-pocket spending as a
proportion of spending on health. This suggests that
households are spending out of pocket, but not in ways
that threaten their economic wellbeing or ability to cover
basic needs.
Based on analyses of the ENIGH, the proportion of outof-pocket spending ﬁnanced by the poor and those with
Seguro Popular has fallen. 13·7% of total out-of-pocket
spending in 2002, and 12·8% in 2004 came from the 40%
poorest households. By 2010, the value had dropped to
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capita allocation of public resources fell more than 70%
between 2004 and 2010 (table 6).
Yet, mobilising additional funds to extend health
insurance coverage is a necessary but not suﬃcient
condition to expand access to comprehensive health
care and decrease reliance on out-of-pocket spending.
Translation of additional ﬁnancial resources into
regular access to comprehensive, eﬀective health
services—the ultimate goals of eﬀective universal
coverage—is a formidable task. Until universal access
includes a guaranteed, acceptable level of quality, the
egalitarian exercise of the right to protection of health
will remain an elusive goal and ineﬃcient out-of-pocket
spending will grow. Further, without eﬃcient use of
current resources, generating the additional ﬁscal space
required to face the burden of chronic diseases is
politically unfeasible.
Gaps and inequities in public funding across
institutions and hence populations have been reduced.
Yet the reliance on ineﬃcient out-of-pocket spending
as a source of health ﬁnancing has not declined
substantially. Out-of-pocket spending persists (alongside
reductions in the prevalence of catastrophic spending)
because families face issues with access and quality.
Finally, gaps in access persist because of continuous
limitations in crucial health-care inputs, especially
human and organisational resources.

11·4% of total out-of-pocket spending. The percentages
are 58·2% in 2002, 52·8% in 2004, and 35·7% in 2010 for
the uninsured and Seguro Popular enrollees.
The 2005–06 assessment results show that Seguro
Popular is reducing out-of-pocket spending and providing ﬁnancial protection, especially for the poorest
households, with a 23% reduction from baseline in
CHE.60,122 The ﬁndings were conﬁrmed in the follow-up
in 2008.59,101 Seguro Popular enrolled households were
signiﬁcantly less likely than either households with
social security or without any ﬁnancial protection, to
spend out of pocket on drugs or outpatient services.
Seguro Popular households also had a signiﬁcantly lower
rate of CHE than did households eligible for Seguro
Popular and not yet enrolled, and lower, although not
signiﬁcantly diﬀerent, to households with access to
social security.
Recent studies conﬁrm this protective eﬀect of Seguro
Popular, especially among urban households and for
prescription drugs and in rural areas with access to
health facilities.64 Still, the studies highlight the persistent
challenge of protecting households in remote rural areas
with very limited access.

Ongoing challenges to the SSPH
Seguro Popular is successfully closing the gaps in health
ﬁnancing across population groups. The gap in the per

2004

2009–10*

Gap‡
NonSocial
(c=a/b)
security† social
security
(a)
(b)

NonSocial
security† social
security
(d)
(e)

Percentage of change
Gap‡
(f=d/e)

Social security†
Non-social security Progress
(g=([d/a]–1)×100) (h=([e/b]–1)×100) in gap
reduction
(%)§

Financing
Public resources per capita (US$ PPP)

209

102

2·1

237

205

1·2

13·1

102·2

74·2%

Service provision: activity levels (rate per 1000)
Outpatient consultations: general

1865

1626

1·3

2110

1834

1·4

13·1

12·8

–2·0%

Outpatient consultations: specialty

1137

438

3·0

1226

573

2·6

7·9

30·9

13·3%

55

39

1·7

54

49

1·3

–2·3

25·8

69·7%

16·8

12·3

1·4

17·8

11·1

1·6

5·9

–9·9

–41·1%

1·6 1·8

2·3

1·6

1·4

–20·5

2·4

35·7%

81·8

70·7

1·2

7·6

2·9

–41·2%
100·0%

Hospital discharges
Service provision: productivity
Consultations per general physician
Consultations per specialist physician
Hospital bed occupancy rates (%)

2·9
76·0

68·7

1·1

Resource generation (rate per 100 000)
General doctors

41

32

1·3

50

50

1·0

21·7

57·9

Specialist doctors

78

40

2·0

90

60

1·5

15·7

51·6

32·2%

232

155

1·5

250

200

1·3

7·9

29·2

39·8%

88

62

1·4

80

70

1·1

–9·3

13·3

58·3%

Nurses
Hospital beds

PPP=purchasing power parity. *All data except for the indicator on ﬁnancing (2010) correspond to 2009. †Social security refers to the population covered by social security
institutions, while non-social security refers to the population without access to health care through social security institutions, that is the previously uninsured population
targeted by the Seguro Popular. ‡Gaps shown correspond to the ratio of the value observed for the insured by social security divided by the corresponding value for the
previously uninsured; they are read as the number of times the value for those insured by social security exceeds the value for the previously uninsured. The closer to one, the
greater equality between population groups. Although the rates shown do not fully control for diﬀerences in age, sex, or epidemiological proﬁle, gaps in activity levels have
been adjusted by the diﬀerence in mortality rates between both population groups. §Progress in gap reduction is measured as the percentage change in the relative gap
ratios between the 2 years analysed with the following formula (1 – [(e – d) / d] / [(b – a) / a]) × 100.

Table 6: Progress in closing the gaps between population groups by health system function
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A benchmark of reform was to close gaps in public
ﬁnancing between the previously uninsured and those
with access to social security, and this goal has been
largely achieved. Between 2000 and 2010, average out-ofpocket spending as a proportion of income and
disposable income fell. Most of the decline occurred
in the previously uninsured population (later Seguro
Popular enrollees) from 6·3% in 2000, to 5·9% in 2004,
and 4·6% in 2010. By contrast, for households with social
security, out-of-pocket spending as a proportion of
income remained quite constant.
Yet the reduction in out-of-pocket spending has been
less than proportional to the increase in ﬁnancial
resources (tables 4 and 6). Private spending still
accounts for 51% of total health expenditure (out of
pocket is 47·1%; table 3). Thus families continue to rely
on out-of-pocket spending—although at levels that
generate less CHE.
Gaps in access to health care between those with social
security and the previously uninsured who currently have
Seguro Popular have also narrowed. Increased access is
associated with higher utilisation of health services.
Although the use of outpatient consultations and hospital
services have improved over time for the previously
uninsured, rates of utilisation are still higher in social
security beneﬁciaries, as are diﬀerences in specialty
consultations. The gap in the number of consultations per
specialty physician is narrowing, yet diﬀerentials in
general consultations and bed occupancy rates have
increased (table 6). Thus, deﬁciencies persist, especially
for some segments of the population and in speciﬁc states.
The Seguro Popular design includes supply-strengthening components to enhance provider responsiveness to
patients’ needs and expectations. Increased ﬁnancing has
generated improved supply of pharmaceuticals, expansion of facilities, and hiring of personnel. Despite this,
some critical inputs still lag. For example, although the
gap in availability of general physicians was essentially
closed between 2004 and 2009, diﬀerences persist for
specialists and nurses (table 6). Another problem is
resource mobilisation and allocation. This includes slow
ﬂow of resources from federal to state and in turn to local
levels, as well as under-spending, poor transparency and
accountability, and poor managerial performance in the
transfer and use of resources among states. In its initial
phases, Seguro Popular focused 45% of transfers to the
states on supporting the purchase of medicines and basic
medical supplies.123 By 2009, this share fell to 20% as the
demand to cover salaries increased.123
Next steps of implementation require that the current
bottlenecks, especially in some specialties, be solved.
Yet this cannot be immediately remedied as it takes
time to train specialists. For example, to meet the
demand for breast cancer treatment in Seguro Popular,
between 200 and 350 radiation oncologists are needed;
yet only about 25% of this ﬁgure were available when
the disease was included in the catastrophic fund.124
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Indeed, there is evidence of increasing underuse of
high-specialty facilities because of scarcity of personnel.
Average occupancy rates in the new high-specialty
hospitals are 70%—a number that will improve as more
specialists are deployed.125
Finally, improving access in remote rural areas is a
challenge.126 Although rural areas include only a minority
of the population (1% live in localities that do not have
access to public transportation and have fewer than
2500 inhabitants, and 5·4% live in localities with less
than 5000 inhabitants), they are a vulnerable, dispersed,
and hard-to-reach group.126 In remote communities,
health centres continue to operate with poor basic
services, poor telecommunications infrastructure, and
are often staﬀed by medical students.127 Still by
2009, about 50% of these centres were formally
accredited, a required condition in order to provide
services to Seguro Popular beneﬁciaries.127
Future planning must account for population ageing
and the growing burden of chronic illness. Although the
number of diseases and interventions covered by the
FPCHE has grown, there are still a host of common,
costly, treatable chronic diseases that are not covered,
including several cancers. This issue is a challenge for
ﬁnancing and for equity; patients with these diseases
suﬀer severe economic hardship or go without treatment.
The prevailing models of ambulatory care were
designed to treat acute disorders. Special eﬀort will be
needed to increase the capacity of primary health centres
to deal with chronic disorders. This implies training in
prevention, early detection, and treatment of chronic
illness, and strengthening telemedicine. Similarly,
capacity is sorely missing for long-term and palliative
care. Further, prevention and appropriate management
of chronic illness—through initiatives such as the
Consulta Segura—are essential to the long-term ﬁnancial
sustainability of the health sector. The FPCHE should
not be overused as a source of ﬁnancing for treatment
because of deﬁciencies in control of risk factors,
prevention, and early detection (panel 5).
Despite substantial improvement on many fronts,
the persistent gaps and imbalances portray structural
limitations in absorptive capacity for the substantial
expansion in resources brought about by the reform. The
competencies and structural changes needed to
eﬃciently manage expansion take time to mature. This
point is especially relevant in the decentralised Mexican
health system where states have diﬀerent degrees of
managerial capacity. Increased ﬁnancial resources
combined with weak management can lead to
ineﬃciency, and solid guidelines combined with careful
monitoring are needed to avoid corruption.
A major challenge is to complete the reorganisation of
the health system by functions. As mentioned above,
consolidation of stewardship at the federal level was
largely achieved and the ﬁnancial architecture of the
entire system was aligned. The next stage of reforms will
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need a fully integrated ﬁnancing scheme with ﬂexibility
and portability of beneﬁts to support delivery by a
plurality of providers, both public and private.131
Another pending challenge is to implement the
purchaser–provider split within states.131 The initial
reform design envisioned a more eﬃcient arrangement
for health-care delivery whereby states would develop the
purchasing function of basic hospital and primary care.
The state Seguro Popular fund holder would allocate
monies through specialised service contracts to a network
of public and private providers (including the states’ own
hospitals and clinics) on the basis of population needs,
rewarding both eﬃcient and responsive care. Local
provision of public goods and provider regulation would
remain part of the stewardship function of state
ministries, working with the federal Ministry of Health.
Yet progress has been slow and uneven as lack of local
capacity compounds with the pressing need to expedite
the supply of basic interventions.
Given successes in ensuring more money for health
and ﬁnancial protection, the emerging challenge for
Seguro Popular is to achieve more health for money. The
Mexican health system is ready for more reform to
address prevailing ineﬃciencies and inequities.

The future of the Mexican health system: a new
generation of reforms
The ultimate objective of the 2003 Mexican health reform
is the egalitarian realisation of the right to social
protection of health, which entails generally applicable
rules of access to a comprehensive package of services
provided with similar quality and ﬁnancial protection to
all. To achieve this objective, the next stage of reform
must encompass ﬁnancial arrangements, managerial
capacities, and operation of the health-care model.
Financial reform should be geared to improved
resource mobilisation. This goal can be accomplished
through an earmarked, social contribution for health
with a combination of progressive, eﬃcient taxes.15,132
This contribution would replace the payroll tax currently
used to ﬁnance much of health care for social security
beneﬁciaries and would further expand general taxation
allocated to health. It should be designed as a single
insurance fund to ﬁnance a common package of
entitlements, including essential and high-specialty
interventions, to which all Mexicans will have access
regardless of the health-service provider.
The full ﬁscal beneﬁts of replacing payroll contributions should also include additional revenues from
eliminating the basis on which ﬁrms can deduct taxes
and disincentivising informality. Pooling resources
across the population would allow more eﬃcient risk
aggregation, especially for high-cost conditions. This
could help with expanded ﬁnancial coverage of catastrophic interventions and help avoid adverse selection.
The purpose of the managerial reform is two-fold: to
consolidate the separation of the ﬁnancing and delivery
www.thelancet.com Vol 380 October 6, 2012

Panel 5: Optimisation of the FPCHE through investment in health promotion
The Fund for Protection against Catastrophic Health Expenditures (FPCHE) covers a
relatively small number of diseases and interventions for which costs of treatment are
high. Without appropriate prevention or control of these diseases, the associated costs
could quickly push the fund into deﬁcit. An example is costly endstage renal disease,
associated with diabetes, which is in turn closely related to the epidemic of overweight
and obesity that must be controlled through health promotion.
In the case of breast cancer, access and adherence to treatment have improved
substantially. The challenge, however, continues to be late detection, which implies
dramatically reduced survival and higher costs per year of life saved.124,128 Investment
expansion is required in the capacity to detect the disease in early stages. As a ﬁrst step,
a specialised training programme was developed for community health workers and
primary-care physicians and nurses, and patient awareness and education were
introduced into Oportunidades.129,130 Still, and despite important investments in the
purchase of mammography units, the lack of specialised breast radiologists is a major
obstacle, especially in certain states.69,124
An integrated approach is needed to meet the challenge of chronic illness and
catastrophic interventions in Mexico. First, education and economic incentives are
needed to manage risk factors and promote prevention. Second, health ﬁnancing and
delivery must be aligned to guarantee investment in all stages of chronic disease.129 In the
case of the System of Social Protection in Health, this involves the three major funds—
community health, Seguro Popular funding for essential interventions, and the FPCHE—
since the management of some diseases requires a combination of public goods, essential
personal health services, and highly specialised interventions. If investment is guaranteed
only for treatment, results will be suboptimum both in terms of costs and lives saved.

functions in all public institutions, and to strengthen
managerial capacity at all levels. The separation of
functions guarantees provision by a plurality of providers,
both public and private, favouring good performance and
quality of care. Ensuring an eﬃcient articulation between
payers and providers is essential to this process.131
Strengthening managerial capacity requires a universal
health identiﬁcation number and card that would
guarantee the portability of beneﬁts, as well as common
capitation and reimbursement rates to help with mobility
of users across providers and to enhance responsiveness.
The reform of the health-care model will adapt service
delivery to meet the challenge of chronic disorders and
injuries, by creating healthy environments and extension
of health care beyond medical facilities. The new model
should prompt the construction of community spaces for
health promotion and emphasise prevention; create
networks of services to assure the continuity of care, and
integrate formal and informal spaces through the
extension of the supply of health-care services to the
home, schools, workplaces, and public areas. This model
should harness telemedicine to reach remote areas, and
regionalise the provision of high-specialty services.
In this process of consolidation, it will be important to
protect the investment in non-personal, community
health services. Reforms in other countries have suﬀered
from not paying enough attention to public health.41 In
Mexico, the next step is to adjust the law to assign a ﬁxed
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percentage of the health budget to the Fund for
Community Health Services. To date, this Fund is
ﬁnanced through an annual allocation that is exposed to
the ebbs and ﬂows of budgets, although the package of
services is explicit and complementary funding has been
identiﬁed through the provision for primary prevention
in the Seguro Popular. Yet the potential economies of
aggregating and integrating interventions suggest that
investing in upstream, preventive and early detection
services—that tend to not have enough spontaneous
demand—will reduce downstream costs and suﬀering,
especially for chronic illness. This is the rationale for
ﬁxing a percentage for this fund.
Sound evidence must continue to guide the evolution
of the entire health system. Thus, the new reforms must
be accompanied by additional investments in health
systems research, fuelled by a vigorous and rigorous
programme of evidence generation, monitoring and
assessment.

Global implications of the Mexican health
reform
The Mexican health reform contributes knowledge to the
global movement for universal health coverage. The
experience is an example of successfully guaranteeing
social protection of health to the non-salaried population
through legislated access to a comprehensive package of
services. Social protection in health is not limited to
those with salaried employment; rather it is a universal
right for all citizens, independent of their employment
status. The experience of applying evidence to design
policy and measure progress also provides models for
strengthening stewardship.133
Indeed, the Mexican experience is being used as a
reference in international work on quality134,135 and in
designing strategies of universal coverage for countries at
all levels of income. In April 2012, this interest resulted in
a Mexico Declaration on universal coverage in an
international forum jointly undertaken by the Mexican
Ministry of Health and WHO that convened 21 countries.136
Various countries have or are undertaking health
ﬁnancing innovation with similarities to Mexico. The
creation of an explicit package of services through the
Regime of Explicit Health Guarantees (AUGE Plan) in
Chile presents parallels with the Mexican FPCHE.137
Another example is the South African systemic ﬁnancial
reform designed to equalise the entitlements of citizens
with access to private insurance and those without.138,139
India has produced an in-depth review of its health
system and policy analysts are calling for a move to
universal health insurance to achieve universal coverage.140,141 Other countries with health reforms that parallel
some aspects of Seguro Popular are Colombia, the
Dominican Republic, Ghana, Peru, Tanzania, Thailand,
Turkey, and Vietnam.142–145,146,147
A lesson from the Mexican experience is the importance
of monitoring and assessment. Evidence has played a
1274

central role in steering the reform process including the
revision of enrolment criteria and the deﬁnition of the
interventions that have been gradually added to the
FPCHE. Assessments have also played a crucial part in
the implementation of accountability mechanisms now
required by law. Several countries and most notably
China, have similarly included a strong measurement
and assessment component in their reforms.147–150 These
data will provide an opportunity to undertake comparative research, especially if rigorous assessment is
built into reforms with similar indicators of progress
towards universal health coverage.
The Mexican experience speaks to the potential to
expand coverage to reach the poor and non-salaried
workers. It is an example of applying legislative reform to
use ﬁnancing from general revenues to cover this
population, building on existing social and antipoverty
programmes that enable outreach and enrolment, such
as Oportunidades. Indeed, both the reform of IMSS in
1997 and the 2003 reform that created the Seguro Popular
increased reliance of the Mexican system on general
taxation and government revenue to ﬁnance health.
The Mexican process points to the importance of
continuity. Good programmes and policies should be
preserved, enriched, and even expanded across administrations when these have been proven eﬀective based
on rigorous assessment.151 The technical capacity of
policy makers helps with this process.
The Mexican experience is especially noteworthy for
having continued despite and throughout economic
downturn and periods of economic crisis.152 Seguro
Popular survived the economic crisis of 2008–09, and
covered services were continually expanded in the wake
of the downturn. This was the result of political will and
commitment to the health of the population. Yet
continuity is also bound by legislative reform, which is
another lesson. Had the reform been built on a series of
programmes, rather than a new law, continuity might
have been questioned. Another lesson is the importance
of long-term investment in the development of research
and educational institutions that generate evidence for
policy design and implementation. These institutions
also train leaders to occupy policy-making positions at
the local and federal levels providing the managerial
capacity to implement reform.
The Mexican reform shows that, although challenging,
developing countries can expand ﬁnancial coverage for
treatment of chronic diseases. Part of the global
community has been convinced that middle-income and
especially low-income countries should limit their
activities to prevention in the case of chronic and noncommunicable diseases.153,154 The Mexican case shows
that developing nations can build ﬁscally responsible
mechanisms, such as the FPCHE, to ﬁnance costeﬀective treatment for chronic diseases alongside
prevention.42,155 Fiscally responsible reform implies the
design and implementation of not only health policies
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but also healthy policies that deal with social
determinants.
The creation of a separate and protected fund for public
goods, and especially community health services and
personal and non-personal public health interventions, is
another ﬁnding. This creation oﬀers a way to extend other
services without neglecting, and indeed while expanding,
health promotion, disease prevention, and early detection
services. Civil society has also contributed to the process
of implementing the reform by sharing knowledge and
encouraging patient involvement, which in turn builds
responsiveness. Further, civil society provides complementary services for better delivery of care.
The Mexican health system has proﬁted from a clear
deﬁnition of priorities, which are important not only in
terms of resource allocation, but also to garner public
support. Distinctive initiatives of the Mexican reform,
such as MING and Fair Start in Life, were also used to
bridge the divide between the vertical and horizontal
approaches to health care through the development of
what has been called the diagonal strategy.156 These
initiatives show that it is possible to use explicit, highpriority interventions to drive system-wide improvement
(ie, in quality)134,135 into the overall health system.
Together, the instruments designed and implemented
in Mexico constitute a map to expand the three
dimensions of social protection of health: against health
risks; for patients by assuring safety, eﬀectiveness, and
responsiveness; and against the ﬁnancial consequences
of disease.
The Mexican quest for universal health coverage and
the creation of the System of Social Protection in Health
through legislative reform encompasses 9 years of well
documented eﬀorts to achieve universality. These eﬀorts
can be adapted and translated for other countries seeking
to provide universal coverage against threats to the health
security of individuals and populations. Learning from
this experience—both its successes and its challenges—
will not only continue to improve health conditions and
ﬁnancial protection for all people in Mexico, but will also
contribute to the global movement towards universal
health coverage.
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